Education
About Us
Working with TipRanks
Follow Us
Anteris Technologies Global Corp. (AVR)
:AVR
AVR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.34 - $8.79
Previous Close$5.88
Volume157.53K
Average Volume (3M)273.65K
Market Cap
$118.28M
Enterprise Value$128.81M
Total Cash (Recent Filing)$48.95M
Total Debt (Recent Filing)$2.02M
Price to Earnings (P/E)―
Beta1.70
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.12
Shares Outstanding36,062,370
10 Day Avg. Volume187,938
30 Day Avg. Volume273,648
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)15.18
Price to Sales (P/S)0.00
P/FCF Ratio-4.41
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue13.08
Enterprise Value/Gross Profit97.42
Enterprise Value/Ebitda-0.50
Forecast
1Y Price Target
$15.00Price Target Upside357.32% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Anteris Technologies Global Corp. News
PremiumCompany Announcements
Anteris Technologies Appoints New Board Members
PremiumCompany Announcements
Anteris Technologies Achieves Key Milestone in Cardiac Care
PremiumCompany Announcements
Anteris Technologies Unveils Positive DurAVR® Patient OutcomesBulls Say, Bears Say
Bulls Say
Clinical PerformanceThe DurAVR system has delivered premier acute and long-term hemodynamic outcomes in early studies.
Product DevelopmentAnteris has developed DurAVR, a first-in-class biomimetic TAVR platform with disruptive potential.
Bears Say
Regulatory ChallengesThe company engaged in multiple pre-submission meetings with the FDA to review critical aspects of the pivotal trial.
Options Prices
Currently, No data available
---
Ownership Overview
0.21% Insiders
0.67% Mutual Funds
51.71% Other Institutional Investors
44.41% Public Companies and
Individual Investors
AVR FAQ
What was Anteris Technologies Global Corp.’s price range in the past 12 months?
Anteris Technologies Global Corp. lowest stock price was $2.34 and its highest was $8.79 in the past 12 months.
What is Anteris Technologies Global Corp.’s market cap?
Anteris Technologies Global Corp.’s market cap is $118.28M.
When is Anteris Technologies Global Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Anteris Technologies Global Corp.’s earnings last quarter?
Currently, no data Available
Is Anteris Technologies Global Corp. overvalued?
According to Wall Street analysts Anteris Technologies Global Corp.’s price is currently Undervalued.
Does Anteris Technologies Global Corp. pay dividends?
Anteris Technologies Global Corp. does not currently pay dividends.
What is Anteris Technologies Global Corp.’s EPS estimate?
Anteris Technologies Global Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anteris Technologies Global Corp. have?
Anteris Technologies Global Corp. has 36,062,370 shares outstanding.
What happened to Anteris Technologies Global Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Anteris Technologies Global Corp.?
Currently, no hedge funds are holding shares in AVR
Anteris Technologies Global Corp. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (357.32% Upside)
$15.00 (357.32% Upside)
Hedge Fund Trend
Decreased
By 85.0K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-341.85%
Trailing 12-Months
Asset Growth
253.11%
Trailing 12-Months
Company Description
Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. was incorporated in 1999 and is based in Toowong, Australia.
AVR Stock 12 Month Forecast
Average Price Target
$15.00
▲(357.32%Upside)